View Item 

Show simple item record

Whitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making
dc.contributor.authorWhitney, Daniel G
dc.contributor.authorBasu, Tanima
dc.date.accessioned2021-07-01T20:14:10Z
dc.date.available2022-08-01 16:14:09en
dc.date.available2021-07-01T20:14:10Z
dc.date.issued2021-07
dc.identifier.citationWhitney, Daniel G; Basu, Tanima (2021). "Whitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making." Developmental Medicine & Child Neurology (7): 853-859.
dc.identifier.issn0012-1622
dc.identifier.issn1469-8749
dc.identifier.urihttps://hdl.handle.net/2027.42/168367
dc.publisherWiley Periodicals, Inc.
dc.titleWhitney Comorbidity Index to monitor health status for adults with cerebral palsy: validation and thresholds to assist clinical decision making
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168367/1/dmcn14879_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168367/2/dmcn14879-sup-0006-FigS3.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168367/3/dmcn14879-sup-0005-FigS2.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168367/4/dmcn14879.pdf
dc.identifier.doi10.1111/dmcn.14879
dc.identifier.sourceDevelopmental Medicine & Child Neurology
dc.identifier.citedreferenceJarosek S. Death information in the research identifiable Medicare data [Internet]. 2018. Available at: https://www.resdac.org/articles/death‐information‐research‐identifiable‐medicare‐data#:~:text=Overall%2C%2099%25%20of%20death%20days%20have%20been%20validated.,‐The%20most%20common&text=However%2C%20RRB%20beneficiaries%20comprise%20a,and%2098%25%20are%20SSA%20beneficiaries (accessed 14 December 2020).
dc.identifier.citedreferencePeterson MD, Hurvitz EA. Cerebral palsy grows up. Mayo Clin Proc 2021; Forthcoming https://doi.org/10.1016/j.mayocp.2020.10.006.
dc.identifier.citedreferenceMcColl MA, Forster D, Shortt SE, et al. Physician experiences providing primary care to people with disabilities. Healthc Policy 2008; 4: e129 – 47.
dc.identifier.citedreferenceWhitney DG, Kamdar NS. Development of a new comorbidity index for adults with cerebral palsy and comparative assessment with common comorbidity indices. Dev Med Child Neurol 2021; 63: 313 – 9.
dc.identifier.citedreferenceCharlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373 – 83.
dc.identifier.citedreferenceWhitney DG. Prevalence of high‐burden medical conditions among young and middle‐aged adults with pediatric‐onset medical conditions: findings from US private and public administrative claims data. Int J Health Policy Manag 2019; 8: 629 – 35.
dc.identifier.citedreferenceChang HY, Weiner JP, Richards TM, Bleich SN, Segal JB. Validating the adapted Diabetes Complications Severity Index in claims data. Am J Manag Care 2012; 18: 721 – 6.
dc.identifier.citedreferenceElixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998; 36: 8 – 27.
dc.identifier.citedreferenceSultan AA, West J, Grainge MJ, et al. Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study. BMJ 2016; 355: i6253.
dc.identifier.citedreferenceUno H, Cai T, Pencina MJ, D’Agostino RB, Wei LJ. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med 2011; 30: 1105 – 17.
dc.identifier.citedreferenceOgundimu EO, Altman DG, Collins GS. Adequate sample size for developing prediction models is not simply related to events per variable. J Clin Epidemiol 2016; 76: 175 – 82.
dc.identifier.citedreferenceWhitney DG, Caird MS, Jepsen KJ, et al. Elevated fracture risk for adults with neurodevelopmental disabilities. Bone 2020; 130: 115080.
dc.identifier.citedreferenceGkaliagkousi E, Gavriilaki E, Vasileiadis I, et al. Endothelial microvesicles circulating in peripheral and coronary circulation are associated with central blood pressure in coronary artery disease. Am J Hypertens 2019; 32: 1199 – 205.
dc.identifier.citedreferenceBalandin S, Berg N, Waller A. Assessing the loneliness of older people with cerebral palsy. Disabil Rehabil 2006; 28: 469 – 79.
dc.identifier.citedreferenceWhitney DG, Warschausky SA, Ng S, Hurvitz EA, Kamdar NS, Peterson MD. Prevalence of mental health disorders among adults with cerebral palsy a cross‐sectional analysis. Ann Int Med 2019; 171: 328 – 33.
dc.identifier.citedreferenceStreiner DL. Comorbidity indices: how should they be developed? Dev Med Child Neurol 2021; 63: 246.
dc.identifier.citedreferenceRosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl 2007; 109: 8 – 14.
dc.identifier.citedreferenceFrench ZP, Caird MS, Whitney DG. Osteoporosis epidemiology among adults with cerebral palsy: findings from private and public administrative claims data. JBMR Plus 2019; 3: e10231.
dc.identifier.citedreferenceFrench ZP, Torres RV, Whitney DG. Elevated prevalence of osteoarthritis among adults with cerebral palsy. J Rehabil Med. 2019; 51: 575 – 81.
dc.identifier.citedreferenceWhitney DG, Alford AI, Devlin MJ, Caird MS, Hurvitz EA, Peterson MD. Adults with cerebral palsy have higher prevalence of fracture compared with adults without cerebral palsy independent of osteoporosis and cardiometabolic diseases. J Bone Miner Res 2019; 34: 1240 – 7.
dc.identifier.citedreferenceWhitney DG, Hurvitz EA, Devlin MJ, et al. Age trajectories of musculoskeletal morbidities in adults with cerebral palsy. Bone 2018; 114: 285 – 91.
dc.identifier.citedreferenceWhitney DG, Hurvitz EA, Ryan JM, et al. Noncommunicable disease and multimorbidity in young adults with cerebral palsy. Clin Epidemiol 2018; 10: 511 – 9.
dc.identifier.citedreferenceWhitney DG, Kamdar NS, Ng S, Hurvitz EA, Peterson MD. Prevalence of high‐burden medical conditions and health care resource utilization and costs among adults with cerebral palsy. Clin Epidemiol 2019; 11: 469 – 81.
dc.identifier.citedreferenceWhitney DG, Schmidt M, Bell S, Morgenstern H, Hirth RA. incidence rate of advanced chronic kidney disease among privately insured adults with neurodevelopmental disabilities. Clin Epidemiol 2020; 12: 235 – 43.
dc.identifier.citedreferenceWhitney DG, Warschausky SA, Ng S, Hurvitz EA, Kamdar NS, Peterson MD. Prevalence of mental health disorders among adults with cerebral palsy: a cross‐sectional analysis. Ann Intern Med 2019; 171: 328 – 33.
dc.identifier.citedreferenceRyan JM, Peterson MD, Ryan N, et al. Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy. Dev Med Child Neurol 2019; 61: 924 – 8.
dc.identifier.citedreferenceCremer N, Hurvitz EA, Peterson MD. Multimorbidity in middle‐aged adults with cerebral palsy. Am J Med 2017; 130: 744.e9 – 744.e15.
dc.identifier.citedreferenceSmith KJ, Peterson MD, O’Connell NE, et al. Risk of depression and anxiety in adults with cerebral palsy. JAMA Neurol 2019; 76: 294 – 300.
dc.identifier.citedreferencevan der Slot WM, Roebroeck ME, Nieuwenhuijsen C, et al. Cardiovascular disease risk in adults with spastic bilateral cerebral palsy. J Rehabil Med 2013; 45: 866 – 72.
dc.identifier.citedreferenceVan Der Slot WM, Nieuwenhuijsen C, Van Den Berg‐Emons RJ, et al. Chronic pain, fatigue, and depressive symptoms in adults with spastic bilateral cerebral palsy. Dev Med Child Neurol 2012; 54: 836 – 42.
dc.identifier.citedreferenceAisen ML, Kerkovich D, Mast J, et al. Cerebral palsy: clinical care and neurological rehabilitation. Lancet Neurol 2011; 10: 844 – 52.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
dmcn14879_am.pdf
Size:
311.4KB
Format:
PDF
View/Open
Name:
dmcn14879-sup-0006-FigS3.pdf
Size:
101.5KB
Format:
PDF
View/Open
Name:
dmcn14879-sup-0005-FigS2.pdf
Size:
141.1KB
Format:
PDF
View/Open
Name:
dmcn14879.pdf
Size:
288.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.